Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ARNA Arena Pharmaceuticals, Inc. daily Stock Chart
ARNA [NASD]
Arena Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-6.46 Insider Own0.20% Shs Outstand56.66M Perf Week4.47%
Market Cap3.70B Forward P/E- EPS next Y-8.18 Insider Trans-69.71% Shs Float50.26M Perf Month2.04%
Income-322.80M PEG- EPS next Q-2.06 Inst Own80.20% Short Float7.78% Perf Quarter39.37%
Sales5.60M P/S659.91 EPS this Y-210.90% Inst Trans7.65% Short Ratio5.03 Perf Half Y42.47%
Book/sh19.68 P/B3.35 EPS next Y4.10% ROA-27.00% Target Price77.82 Perf Year8.49%
Cash/sh14.27 P/C4.62 EPS next 5Y- ROE-29.30% 52W Range32.95 - 69.75 Perf YTD45.13%
Dividend- P/FCF- EPS past 5Y36.80% ROI33.20% 52W High-5.49% Beta1.46
Dividend %- Quick Ratio18.70 Sales past 5Y85.20% Gross Margin- 52W Low100.06% ATR2.90
Employees320 Current Ratio18.70 Sales Q/Q-100.00% Oper. Margin- RSI (14)59.89 Volatility3.35% 4.38%
OptionableYes Debt/Eq0.05 EPS Q/Q-116.50% Profit Margin- Rel Volume0.35 Prev Close65.75
ShortableYes LT Debt/Eq0.05 EarningsMay 07 AMC Payout- Avg Volume777.44K Price65.92
Recom1.60 SMA203.26% SMA5011.97% SMA20032.46% Volume272,501 Change0.26%
Jun-29-20Initiated H.C. Wainwright Buy $90
May-18-20Initiated Jefferies Buy $62
Mar-31-20Initiated Guggenheim Buy $95
Mar-26-20Upgrade BofA/Merrill Neutral → Buy $47 → $56
Jan-31-20Upgrade JP Morgan Neutral → Overweight $58
Nov-13-19Initiated BofA/Merrill Neutral $51
Dec-13-18Initiated Berenberg Buy $55
May-31-18Initiated RBC Capital Mkts Outperform $65
Mar-21-18Upgrade Needham Hold → Buy $60
Mar-20-18Reiterated JMP Securities Mkt Outperform $63 → $79
Jan-18-18Resumed Credit Suisse Outperform $44
Jan-18-18Initiated Credit Suisse Outperform $44
Jan-03-18Upgrade Wells Fargo Market Perform → Outperform
Jul-11-17Reiterated Citigroup Buy $23 → $37
Jul-07-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jun-27-17Initiated Citigroup Buy $23
May-19-17Initiated Leerink Partners Outperform $5
Sep-15-16Initiated FBR & Co. Outperform $6
Mar-01-16Reiterated RBC Capital Mkts Sector Perform $2 → $1.50
Nov-11-15Reiterated RBC Capital Mkts Sector Perform $5 → $2
Jun-18-20 04:01PM  
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Jun-15-20 08:30AM  
Arena Pharmaceuticals Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
PR Newswire
Jun-08-20 04:30PM  
Arena Pharmaceuticals Announces R&D Leadership Transition
PR Newswire
01:28PM  
Edited Transcript of ARNA earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents
Jun-03-20 01:13AM  
Hedge Funds Arent Done Buying Arena Pharmaceuticals, Inc. (ARNA)
Insider Monkey
Jun-02-20 04:23PM  
Why Bristol Myers' Success In Ulcerative Colitis Sent Arena Stock Flying
Investor's Business Daily +16.22%
Jun-01-20 04:01PM  
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
PR Newswire
09:30AM  
Moving Average Crossover Alert: Arena Pharmaceuticals
Zacks
May-28-20 08:30AM  
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
PR Newswire
May-27-20 04:01PM  
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
PR Newswire
May-26-20 08:30AM  
Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates
PR Newswire
May-22-20 04:30PM  
Arena Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
PR Newswire
May-20-20 04:01PM  
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
May-19-20 04:10PM  
Galecto Appoints New Chair and Strengthens Board of Directors
GlobeNewswire
May-13-20 04:01PM  
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
PR Newswire -6.92%
09:18AM  
Is Arena (ARNA) Stock a Solid Choice Right Now?
Zacks
May-10-20 08:18AM  
Earnings Update: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Just Reported And Analysts Are Trimming Their Forecasts
Simply Wall St.
May-08-20 03:01PM  
Arena Pharmaceuticals Inc (ARNA) Q1 2020 Earnings Call Transcript
Motley Fool
10:39AM  
Arena Pharmaceuticals (ARNA) Q1 Loss Narrower Than Expected
Zacks
May-07-20 04:01PM  
Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results
PR Newswire
May-06-20 08:30AM  
Arena Pharmaceuticals to Present at the Bank of America Securities Healthcare Conference on May 13
PR Newswire
Apr-30-20 08:30AM  
Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7
PR Newswire
Apr-24-20 09:00AM  
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Apr-19-20 08:27AM  
If You Had Bought Arena Pharmaceuticals (NASDAQ:ARNA) Shares Three Years Ago You'd Have Made 283%
Simply Wall St.
Apr-14-20 01:47PM  
ESPAÑOL Empresas de Cannabis con Acciones el NYSE y NASDAQ: Una Lista Completa
Benzinga
Apr-10-20 01:09PM  
Arena Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference on April 14
PR Newswire
Apr-07-20 08:05PM  
Hedge Funds Have Never Been This Bullish On Arena Pharmaceuticals, Inc. (ARNA)
Insider Monkey
Apr-01-20 04:01PM  
Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)
PR Newswire
Mar-30-20 08:30AM  
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
PR Newswire -5.43%
Mar-18-20 04:01PM  
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire -11.19%
02:29PM  
Top Biotech Stocks for Q2 2020
Investopedia
Mar-09-20 01:30PM  
6 Cheap Health Care Stocks
GuruFocus.com -6.58%
10:18AM  
Arena's Pipeline Holds Promise, Plunging Revenues a Concern
Zacks
Feb-28-20 05:38AM  
Arena Pharmaceuticals, Inc. Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Simply Wall St.
Feb-27-20 01:48PM  
Edited Transcript of ARNA earnings conference call or presentation 26-Feb-20 9:30pm GMT
Thomson Reuters StreetEvents -5.75%
10:40AM  
Arena Pharmaceuticals (ARNA) Q4 Earnings Miss, Revenues Top
Zacks
Feb-26-20 04:01PM  
Arena Announces Management and Program Updates and Reports Fourth Quarter and Full-Year 2019 Financial Results
PR Newswire
09:36AM  
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
Benzinga
Feb-21-20 04:11PM  
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Feb-20-20 08:30AM  
Arena Pharmaceuticals to Present at the Upcoming Investor Conferences
PR Newswire
Feb-19-20 04:06PM  
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2019 Financial Results and Provide Corporate Update on February 26
PR Newswire
Feb-13-20 06:09AM  
Our Take On Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary
Simply Wall St.
Feb-11-20 03:06PM  
Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community
PR Newswire
Jan-31-20 03:45PM  
Top Marijuana Stocks on the NASDAQ
Investopedia
Jan-17-20 08:16AM  
Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status
Zacks
Jan-16-20 09:00AM  
FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients
PR Newswire
Jan-13-20 04:01PM  
Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary
PR Newswire
Jan-08-20 09:27AM  
2019 Review: Top Hedge Fund Stocks vs. Arena Pharmaceuticals, Inc. (ARNA)
Insider Monkey
08:30AM  
Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16
PR Newswire
Jan-07-20 07:57AM  
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
Benzinga
Jan-06-20 04:01PM  
Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND Per Year for the Next 5 Years
PR Newswire
Jan-03-20 09:01AM  
Arena (ARNA) Expands Strategic Deal With Beacon Discovery
Zacks
Jan-02-20 08:30AM  
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets
PR Newswire
Dec-30-19 08:52AM  
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A Volatile Stock?
Simply Wall St.
Dec-19-19 02:32PM  
6 Stocks With Low Price-Earnings Ratios
GuruFocus.com
Dec-13-19 02:31PM  
The MLB allows players to smoke marijuana
Yahoo Finance Video
Dec-03-19 04:35PM  
Hedge Funds Are Done Buying Arena Pharmaceuticals, Inc. (ARNA)?
Insider Monkey
Nov-27-19 06:34PM  
Edited Transcript of ARNA earnings conference call or presentation 7-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Nov-26-19 08:30AM  
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
PR Newswire
Nov-18-19 04:01PM  
California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA Awards for the Deal of the Year
PR Newswire
Nov-14-19 09:00AM  
Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia
GlobeNewswire
Nov-10-19 07:43AM  
Can You Imagine How Chuffed Arena Pharmaceuticals's (NASDAQ:ARNA) Shareholders Feel About Its 189% Share Price Gain?
Simply Wall St.
Nov-08-19 08:56AM  
Arena Pharmaceuticals' (ARNA) Q3 Loss Widens, Revenues Beat
Zacks
Nov-07-19 04:01PM  
Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs
PR Newswire
Nov-06-19 08:30AM  
Arena Pharmaceuticals Presented New Data Highlighting the Human Mass Balance and Metabolism Profile of Etrasimod at AAPS
PR Newswire
Nov-05-19 05:41PM  
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
PR Newswire
Oct-31-19 11:45AM  
United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up
Zacks
08:30AM  
Arena Pharmaceuticals to Release Third Quarter 2019 Financial Results and Provide Corporate Update on November 7
PR Newswire
Oct-28-19 08:30AM  
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
PR Newswire
Oct-23-19 01:26PM  
Hedge Funds Have Never Been This Bullish On Arena Pharmaceuticals, Inc. (ARNA)
Insider Monkey
Oct-22-19 04:01PM  
Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week
PR Newswire
Oct-18-19 03:01AM  
Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community
PR Newswire
Oct-05-19 09:51AM  
What Kind Of Shareholder Owns Most Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock?
Simply Wall St.
Sep-26-19 08:30AM  
Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting
PR Newswire -6.14%
Sep-25-19 08:30AM  
Arena Pharmaceuticals to Present at the Cantor Global Healthcare Conference on October 2
PR Newswire
Sep-17-19 08:30AM  
Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting
PR Newswire
Sep-12-19 11:25AM  
United Therapeutics' Trevyent NDA for PAH Accepted by FDA
Zacks
Sep-10-19 11:15PM  
Arena Pharmaceuticals Inc (ARNA) EVP, General Counsel & Sec Steven W Spector Sold $2. ...
GuruFocus.com
Sep-09-19 08:30AM  
Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting
PR Newswire
Sep-05-19 11:23AM  
Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others?
Simply Wall St.
Aug-28-19 08:30AM  
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
PR Newswire
Aug-13-19 12:44PM  
25 Biggest Marijuana Companies in the World
Insider Monkey
Aug-08-19 04:47PM  
Edited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMT
Thomson Reuters StreetEvents -7.77%
04:08PM  
This Biotech Crashed On 'Erroneous' Report Plus 2 Stocks That Diverged
Investor's Business Daily
10:34AM  
Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet
Zacks
04:23AM  
Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript
Motley Fool
Aug-07-19 04:01PM  
Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials
PR Newswire
Aug-06-19 03:50PM  
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own?
Simply Wall St.
Aug-01-19 09:49AM  
United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y
Zacks
Jul-31-19 08:30AM  
Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7
PR Newswire
Jul-29-19 10:34AM  
Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for
Zacks
Jul-25-19 09:00AM  
Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why
Zacks
08:30AM  
Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome
PR Newswire
Jul-09-19 01:32PM  
Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick?
Simply Wall St.
Jun-18-19 12:30PM  
A Company's First Profit Can Mean Big Profits for Investors
Zacks
10:38AM  
Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod
Zacks
Jun-17-19 08:30AM  
Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis
PR Newswire
Jun-14-19 06:29PM  
Did Hedge Funds Drop The Ball On Arena Pharmaceuticals, Inc. (ARNA)
Insider Monkey
Jun-13-19 06:29PM  
Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT
Thomson Reuters StreetEvents
08:30AM  
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
PR Newswire
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Soni Manmeet SinghDirectorJun 17Sale62.7430419,0735,902Jun 18 05:07 PM
Soni Manmeet SinghDirectorJun 15Sale60.121,32779,7796,206Jun 16 08:54 PM
Munshi AmitPresident and CEOJun 03Option Exercise15.3550,000767,67557,750Jun 04 06:34 PM
Munshi AmitPresident and CEOJun 03Sale68.5450,0003,427,2367,750Jun 04 06:34 PM
Aurentz VincentExecutive VP and CBOJun 02Option Exercise19.8025,000495,00025,000Jun 04 06:40 PM
Munshi AmitPresident and CEOJun 02Option Exercise14.6050,000730,00057,750Jun 04 06:34 PM
Munshi AmitPresident and CEOJun 02Sale65.0050,0003,250,0007,750Jun 04 06:34 PM
Aurentz VincentExecutive VP and CBOJun 02Sale65.0025,0001,625,0230Jun 04 06:40 PM
Munshi AmitPresident and CEOMay 22Option Exercise14.6034,800508,08042,550May 22 07:31 PM
Munshi AmitPresident and CEOMay 22Sale58.1234,8002,022,6087,750May 22 07:31 PM
Munshi AmitPresident and CEOMay 21Option Exercise14.6050,000730,00057,750May 22 07:31 PM
Munshi AmitPresident and CEOMay 21Sale55.0050,0002,750,0007,750May 22 07:31 PM
SPECTOR STEVEN WEVP, General Counsel & SecFeb 27Option Exercise14.907,970118,75317,437Feb 28 06:02 PM
SPECTOR STEVEN WEVP, General Counsel & SecFeb 13Option Exercise35.647,436265,00120,303Feb 14 07:43 PM
Munshi AmitPresident and CEOFeb 13Option Exercise14.6015,200221,92022,950Feb 14 07:37 PM
Lind Kevin RobertExecutive VP and CFOFeb 13Option Exercise26.604,500119,7007,957Feb 14 07:40 PM
Munshi AmitPresident and CEOFeb 13Sale55.0015,200836,0007,750Feb 14 07:37 PM
SPECTOR STEVEN WEVP, General Counsel & SecFeb 13Sale55.0010,836595,9809,467Feb 14 07:43 PM
Lind Kevin RobertExecutive VP and CFOFeb 13Sale55.004,500247,5003,457Feb 14 07:40 PM
Aurentz VincentExecutive VP and CBOFeb 05Sale50.009,000450,0000Feb 07 04:34 PM
Munshi AmitPresident and CEOFeb 05Sale50.007,129356,4507,750Feb 07 04:31 PM
Lisicki RobertEVP, Chief Commercial OfficerNov 13Sale45.834,429203,0000Nov 26 05:44 PM
WOODS RANDALL EDirectorNov 12Option Exercise32.503,04698,99517,276Nov 13 08:14 PM
WOODS RANDALL EDirectorNov 12Sale46.733,046142,34014,230Nov 13 08:14 PM
SPECTOR STEVEN WEVP, General Counsel & SecOct 14Option Exercise0.006,300015,990Oct 16 08:22 PM
Lisicki RobertEVP, Chief Commercial OfficerOct 14Option Exercise0.006,30006,300Oct 16 08:21 PM
Klassen PrestonEVP and CMOOct 14Option Exercise0.006,30006,300Oct 16 08:20 PM
Aurentz VincentExecutive VP and CBOOct 14Option Exercise0.009,00009,000Oct 16 08:19 PM
Lind Kevin RobertExecutive VP and CFOOct 14Option Exercise0.006,30006,548Oct 16 08:18 PM
Munshi AmitPresident and CEOOct 14Option Exercise0.0011,700019,450Oct 16 08:17 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 10Option Exercise15.5012,627195,71922,317Sep 10 09:03 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 10Sale50.2812,627634,8739,690Sep 10 09:03 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 09Option Exercise18.7421,457402,18641,147Sep 10 09:03 PM
Aurentz VincentExecutive VP and CBOSep 09Option Exercise25.2565,0001,641,50065,000Sep 10 09:05 PM
Aurentz VincentExecutive VP and CBOSep 09Sale50.7265,0003,296,7000Sep 10 09:05 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 09Sale50.7231,4571,595,5159,690Sep 10 09:03 PM
open in yahoo | open in reuters | open in google